CD21 Antibody (21B9) Summary
| Immunogen |
Unfortunately, this information is considered to be commercially sensitive
|
| Localization |
Type I membrane protein
|
| Marker |
Histiocytic Marker
|
| Specificity |
This clone 21B9 reacts with CD21 on 8-cells and dendritic cells. The monoclonal 21B9 is a unique which is also useful to recognize cells with low CD21 expression, such as, a subset of T cells, epithelial cells and astrocytes.
|
| Isotype |
IgG3
|
| Clonality |
Monoclonal
|
| Host |
Mouse
|
| Gene |
CR2
|
| Purity |
Protein A or G purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
| Application Notes |
Western Blot Predicted molecular weight 115 kDa.
|
Reactivity Notes
Cross-reacts with Human.
Packaging, Storage & Formulations
| Storage |
Store at 4C. Do not freeze.
|
| Buffer |
0.2 um filtered solution in PBS and 0.1% BSA
|
| Preservative |
0.02% Sodium Azide
|
| Concentration |
0.1 mg/ml
|
| Purity |
Protein A or G purified
|
Alternate Names for CD21 Antibody (21B9)
- C3DR
- C3DRSLEB9
- CD21 antigen
- CD21
- Complement C3d receptor
- complement component (3d/Epstein Barr virus) receptor 2
- complement receptor type 2
- CR2
- EBV receptor
- Epstein-Barr virus receptor
Background
CD21 also known as complement receptor 2 (CR2), C3d receptor or EBV receptor is a 140 kDa protein. CD21 is a glycosylated type I transmembrane protein consisting of an extracellular face of a series of 15 or 16 CCP domains. CD21 is the receptor for complement components C3d and iC3b as well as the Epstein-Barr virus (EBV) glycoprotein gp350/220. The soluble CD21 (sCD21) was shown to efficiently trigger CD23 signalling pathways in human monocytes. By inducing release of proinflammatory cytokines and upregulating expression of molecules involved in antigen presentation, sCD21 modulates critical monocyte functions that may be relevant to allergic and inflammatory disorders.
